Patents by Inventor Hans A. Draayer

Hans A. Draayer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccines and methods to treat canine influenza
    Patent number: 7879336
    Abstract: The present invention relates to providing new vaccines and treatments for the diseases related to canine influenza virus. It discloses influenza viral antigens, and methods of presenting these antigens to canines, especially dogs. It relates to attenuated and killed vaccines. The present invention relates to experimentally generated canine and equine influenza viruses. invention also includes influenza A, including H3, N8, H3N8, H7N7 and viruses which contain at least one genome segment from an canine or equine influenza virus. The present invention also relates to the use of these viruses in therapeutic compositions to protect canines, dogs in particular, from diseases caused by influenza viruses.
    Type: Grant
    Filed: June 23, 2008
    Date of Patent: February 1, 2011
    Assignee: Pharmacia & Upjohn Company, LLC
    Inventors: Shelly L. Shields, Hans A Draayer, Michael J Huether
  • Vaccines and methods to treat canine influenza
    Patent number: 7722884
    Abstract: The present invention relates to providing new vaccines and treatments for the diseases related to canine influenza virus. It discloses influenza viral antigens, and methods of presenting these antigens to canines, especially dogs. It relates to attenuated and killed vaccines. The present invention relates to experimentally generated canine and equine influenza viruses. The invention also includes influenza A, including H3, N8, H3N8, H7N7 and viruses which contain at least one genome segment from an canine or equine influenza virus. The present invention also relates to the use of these viruses in therapeutic compositions to protect canines, dogs in particular, from diseases caused by influenza viruses.
    Type: Grant
    Filed: October 6, 2006
    Date of Patent: May 25, 2010
    Assignee: Pharmacie & Upjohn Company, LLC
    Inventors: Shelly L. Shields, Hans A. Draayer, Michael J. Huether
  • Vaccines and Methods to Treat Canine influenza
    Publication number: 20080254063
    Abstract: The present invention relates to providing new vaccines and treatments for the diseases related to canine influenza virus. It discloses influenza viral antigens, and methods of presenting these antigens to canines, especially dogs. It relates to attenuated and killed vaccines. The present invention relates to experimentally generated canine and equine influenza viruses. invention also includes influenza A, including H3, N8, H3N8, H7N7 and viruses which contain at least one genome segment from an canine or equine influenza virus. The present invention also relates to the use of these viruses in therapeutic compositions to protect canines, dogs in particular, from diseases caused by influenza viruses.
    Type: Application
    Filed: June 23, 2008
    Publication date: October 16, 2008
    Applicant: PHARMACIA AND UPJOHN COMAPNY LLC
    Inventors: Shelly L. Shields, Hans A. Draayer, Michael J. Huether
  • Vaccines and methods to treat canine influenza
    Publication number: 20070082012
    Abstract: The present invention relates to providing new vaccines and treatments for the diseases related to canine influenza virus. It discloses influenza viral antigens, and methods of presenting these antigens to canines, especially dogs. It relates to attenuated and killed vaccines. The present invention relates to experimentally generated canine and equine influenza viruses. The invention also includes influenza A, including H3, N8, H3N8, H7N7 and viruses which contain at least one genome segment from an canine or equine influenza virus. The present invention also relates to the use of these viruses in therapeutic compositions to protect canines, dogs in particular, from diseases caused by influenza viruses.
    Type: Application
    Filed: October 6, 2006
    Publication date: April 12, 2007
    Inventors: Shelly Shields, Hans Draayer, Michael Huether
  • Vaccine based on TGEV for protection of canines against canine coronavirus
    Patent number: 6074651
    Abstract: A method for preventing canine coronavirus in dogs is disclosed which comprises administering to a dog a live or inactivated vaccine prepared from transmissible gastroenteritis virus of swine (a TGEV vaccine). An inactivated vaccine composition for use in such a method and a process for the manufacture of the inactivated vaccine composition are described.
    Type: Grant
    Filed: March 30, 1999
    Date of Patent: June 13, 2000
    Assignee: Pfizer, Inc.
    Inventors: Dale Bordt, Hans Draayer
  • Vaccine based on TGEV for protection of dogs against canine coronavirus
    Patent number: 5911999
    Abstract: A method for preventing canine coronavirus in dogs is disclosed which comprises administering to a dog a live or inactivated vaccine prepared from transmissible gastroenteritis virus of swine (a TGEV vaccine). An inactivated vaccine composition for use in such a method and a process for the manufacture of the inactivated vaccine composition are described.
    Type: Grant
    Filed: March 27, 1991
    Date of Patent: June 15, 1999
    Assignee: Pfizer, Inc.
    Inventors: Dale Bordt, Hans Draayer
  • Vaccine
    Patent number: 5200179
    Abstract: Sterile pharmaceutical compositions for use in therapy especially inactivated vaccines for use in prophylaxis, are prepared by inactivating a live virus or bacterium with ascorbic acid and/or a salt thereof in the presence of oxygen and a source of heavy metal ions. Methods of treating animals, including humans, with such compositions are also disclosed.
    Type: Grant
    Filed: February 13, 1991
    Date of Patent: April 6, 1993
    Assignee: Beecham Group p.l.c.
    Inventors: Dale Bordt, Hans Draayer